GAUDIUMIVF Share Price Target 2050

CAGR-based price projection for Gaudium IVF and Women Health Limited (GAUDIUMIVF) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (6.0% CAGR)
Rs 447
2050 Target
Base Case (15.1% CAGR)
Rs 3,190
2050 Target
Bull Case (42.2% CAGR)
Rs 509,707
2050 Target

Current Market Snapshot

CMP: Rs 109.48
52W High: Rs 128.17
52W Low: Rs 95.13
1Y CAGR: 32.4%
3Y CAGR: 15.1%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 116 Rs 126 Rs 156
2028 Rs 123 Rs 145 Rs 221
2029 Rs 131 Rs 167 Rs 315
2030 Rs 138 Rs 192 Rs 447
2031 Rs 147 Rs 221 Rs 636
2032 Rs 156 Rs 254 Rs 904
2033 Rs 165 Rs 293 Rs 1,286
2034 Rs 175 Rs 337 Rs 1,828
2035 Rs 185 Rs 388 Rs 2,599
2036 Rs 197 Rs 446 Rs 3,695
2037 Rs 209 Rs 513 Rs 5,254
2038 Rs 221 Rs 591 Rs 7,470
2039 Rs 234 Rs 680 Rs 10,621
2040 Rs 249 Rs 783 Rs 15,101
2041 Rs 264 Rs 901 Rs 21,470
2042 Rs 280 Rs 1,037 Rs 30,525
2043 Rs 296 Rs 1,193 Rs 43,400
2044 Rs 314 Rs 1,373 Rs 61,706
2045 Rs 333 Rs 1,580 Rs 87,732
2046 Rs 353 Rs 1,818 Rs 124,735
2047 Rs 375 Rs 2,093 Rs 177,346
2048 Rs 397 Rs 2,408 Rs 252,148
2049 Rs 421 Rs 2,772 Rs 358,499
2050 Rs 447 Rs 3,190 Rs 509,707

Other GAUDIUMIVF Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the GAUDIUMIVF share price target for 2050?

Based on historical growth analysis, the GAUDIUMIVF share price target for 2050 ranges from Rs 447 (conservative) to Rs 3,190 (base case) to Rs 509,707 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GAUDIUMIVF?

The current market price of GAUDIUMIVF (Gaudium IVF and Women Health Limited) is Rs 109.48. The 52-week high is Rs 128.17 and 52-week low is Rs 95.13.

Is GAUDIUMIVF a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GAUDIUMIVF price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 6.0% CAGR), Base (15.1% CAGR), and Bull (optimistic at 42.2% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.